Lv4
630 积分 2021-12-21 加入
Comparing the cardiorespiratory safety of parenteral olanzapine and benzodiazepines to parenteral haloperidol/droperidol and benzodiazepines in emergency department patients
4天前
已完结
Prognostic Implication of t(1;19) in Pediatric Pre-B Acute Lymphoblastic Leukemia: A Nationwide Study
4天前
已完结
Treatment Changes in Patients With Moderate to Severe Psoriasis: A Retrospective Chart Review
4天前
已完结
First-line zorifertinib for EGFR-mutant non-small cell lung cancer with central nervous system metastases: The phase 3 EVEREST trial
7天前
已完结
立体定向放疗与射频消融治疗多原发非小细胞肺癌的临床对比研究
13天前
已关闭
Gefitinib vs Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR-Variant Lung Cancer—Long-Term Results of a Randomized Clinical Trial
25天前
已完结
Radiation Therapy for the Treatment of Unresected Stage I-II Non-small Cell Lung Cancer
26天前
已完结
Nonsurgical Therapy for Early-Stage Lung Cancer
1个月前
已完结
A global initiative to deliver precision health in diabetes
4个月前
已采纳
A review on antimicrobial strategies in mitigating biofilm-associated infections on medical implants
4个月前
已采纳
Prognostic Implications of Quantitative Flow Ratio and Plaque Characteristics in Intravascular Ultrasound–Guided Treatment Strategy
4个月前
已采纳
Fluid inertia controls mineral precipitation and clogging in pore to network-scale flows
4个月前
已采纳
Casting a wider net: The clinical potential of EV transcriptomics in multi-analyte liquid biopsy
4个月前
已采纳
The Genetics of Complex Cholestatic Disorders
4个月前
已采纳
S1058 A Scintigraphic Study to Evaluate the Safety, Tolerability, and Functions of a Drug Delivery System (DDS) Device in Healthy Subjects in Fasted State
4个月前
已采纳
Structure-activity relationships of middle-size cyclic peptides, KRAS inhibitors derived from an mRNA display
4个月前
已采纳
Activation of protein kinase C inhibits uptake, currents and binding associated with the human dopamine transporter expressed in Xenopus oocytes
4个月前
已采纳
Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): first interim results from a randomised, double-blind, multicentre, phase 3 trial
4个月前
已采纳
皖公网安备34019202002308
